Investors

Global pioneer in ophthalmic diagnostics

Revenio is a global pioneer in eye care diagnostics solutions. We operate in the international ophthalmic diagnostic devices market, the growth of which is supported by strong megatrends. The need for eye care will increase globally in the coming years as the population ages, the health care environment changes and lifestyles change. Especially in developed countries, chronic lifestyle diseases such as diabetes are becoming more common and putting a strain on healthcare.

Despite the growing need for eye care, the number of professionals in the field is decreasing. The increasing shortage of resources and skilled workers means that comprehensive and intelligent eye care systems are becoming increasingly important. Revenio’s solutions reduce the burden on healthcare and improve the quality of life of millions of people around the world by enabling more efficient screening, prevention and diagnosis of eye diseases.

The highest-quality product portfolio on the market

Revenio offers fast, easy-to-use and reliable tools for the diagnosis of glaucoma, diabetic retinopathy and age-related macular degeneration. Our product portfolio of the highest-quality ophthalmic diagnostic solutions on the market includes intraocular pressure measurement devices i.e. tonometers, fundus imaging devices, perimeters, microperimeters and software solutions under the iCare brand.

The competitive advantage of our product portfolio is built on four cornerstones: diagnostic reliability and repeatability of results, patient-centric solutions, seamless connectivity and efficient care pathways. Our competitive advantage is protected by patents, regulatory approvals, the strong iCare brand and seamlessly integrated software and algorithms.

Our solutions are designed to seamlessly integrate with wider eye care ecosystems. Our products are available through distributors and our own sales network in more than a hundred countries around the world, supporting eye care professionals and improving patient care worldwide.

Read more

Innovative product development enables future solutions

Revenio has decades of experience in eye care and the industry's leading product development expertise. Our research and development activities combine clinical understanding, technological innovation and user-centric design, enabling continuously evolving, reliable and accurate solutions for the early detection and monitoring of eye diseases. Our ability to build the highest-quality products and solutions on the market gives eye care professionals confidence that their diagnosis is correct and based on sufficient and reliable information. On average, we invest around 10% of our net sales annually in pioneering R&D to launch future eye health solutions and to ensure that we stay ahead of the technology game.

In recent years, we have made a significant journey from being an equipment supplier to becoming a global pioneer in comprehensive eye diagnostics solutions. At the core of our current strategy is the continuous improvement of clinical diagnostics quality through targeted product innovations and the optimization of clinical care pathways through integrated and proactive solutions. We use a product operating model to ensure that we develop solutions for customer needs, allocate resources correctly and make the necessary decisions efficiently. In this way, we will continue to build a sustainable competitive advantage in the future.

Strong financial position as the basis for growth strategy

Revenio has proven its ability to grow profitably and sustainably for over a decade, and we want to continue on this path. We are excellently positioned in an industry with strong structural long-term growth drivers and a high entry threshold. We are at the forefront of creating a new generation of solutions that combine technology and patient-oriented care. This creates significant growth opportunities for us.

Our profitability, which is among the strongest in the industry, and our strong financial position allow us to implement our growth strategy. We are constantly exploring opportunities to expand our product portfolio through either our own product development or acquisitions that fit our strategy, and we see significant long-term potential in new products, software and the use of AI. In particular, software solutions play a significant role in growing traditional hardware sales in both existing and new customer segments. In addition, AI will play an increasingly key role in our solutions related to screening, diagnostics and data management.

We will continue to make significant investments in product development to launch new advanced comprehensive solutions and system innovations to the market. At the same time, we will continue to develop the customer experience, our brand and our sales channels, which are equally key to our success. In this way, we will continue to make our wonderful world visible to everyone, also in the future.

Sustainability is at the heart of our business

Revenio promotes the healthcare sector’s transition toward more efficient care pathways and is committed to ensuring that all of its operations are ethically sustainable and transparent. Through our innovations, we enhance preventive healthcare and improve accessibility, effectiveness, and productivity in healthcare worldwide. The early diagnostics enabled by our devices help reduce the need for intensive treatments and lengthy care pathways, thereby contributing to a lower environmental footprint. Our products are durable and serviceable, reinforcing the principles of responsible manufacturing. By investing in our sustainability efforts and collaborating closely with our supply chain, we aim to develop our products with environmental considerations in mind. In doing so, we create sustainable value for both society and our investors.

Read more